TBCRC026: Phase II trial correlating standardized uptake value with pathologic complete response to pertuzumab and trastuzumab in breast cancer
Roisin M. Connolly, Jeffrey P. Leal, Lilja Solnes, Chiung Yu Huang, Ashley Carpenter, Katy Gaffney, Vandana Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Ian E. Krop, Eric P. Winer, Melissa Camp, Robert S. Miller, Antonio C. Wolff, Ashley Cimino-MathewsBen H. Park, Richard L. Wahl, Vered Stearns
Dive into the research topics of 'TBCRC026: Phase II trial correlating standardized uptake value with pathologic complete response to pertuzumab and trastuzumab in breast cancer'. Together they form a unique fingerprint.